MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin

BACKGROUND: Antibodies to myelin oligodendrocyte glycoprotein (MOG-IgG) have been suggested to play a role in a subset of patients with neuromyelitis optica and related disorders. OBJECTIVE: To assess (i) the frequency of MOG-IgG in a large and predominantly Caucasian cohort of patients with optic n...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarius, Sven, Ruprecht, Klemens, Kleiter, Ingo, Borisow, Nadja, Asgari, Nasrin, Pitarokoili, Kalliopi, Pache, Florence, Stich, Oliver, Beume, Lena-Alexandra, Hümmert, Martin W., Trebst, Corinna, Ringelstein, Marius, Aktas, Orhan, Winkelmann, Alexander, Buttmann, Mathias, Schwarz, Alexander, Zimmermann, Hanna, Brandt, Alexander U., Franciotta, Diego, Capobianco, Marco, Kuchling, Joseph, Haas, Jürgen, Korporal-Kuhnke, Mirjam, Lillevang, Soeren Thue, Fechner, Kai, Schanda, Kathrin, Paul, Friedemann, Wildemann, Brigitte, Reindl, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084340/
https://www.ncbi.nlm.nih.gov/pubmed/27788675
http://dx.doi.org/10.1186/s12974-016-0717-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084340/
https://www.ncbi.nlm.nih.gov/pubmed/27788675
http://dx.doi.org/10.1186/s12974-016-0717-1

Ejemplares similares